T. Rowe Price US Large Cap Growth Equity Fund A USD vs UBS Lux Equity Fund Biotech USD

T. Rowe Price US Large Cap Growth Equity Fund A USD vs UBS Lux Equity Fund Biotech USD

1. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Security

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Fee

    1.59%

  • ISIN

    LU0174119429

  • Holdings

    9

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

Fund Holdings

We have information about 19 holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD, where the largest holding is Microsoft (9.79), followed by Nvidia (9.77) and Apple (9.5). In comparison with UBS Lux Equity Fund Biotech USD, we have 7 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66).

All Holdings

Here we compare the holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD and UBS Lux Equity Fund Biotech USD.

T. Rowe Price US Large Cap Growth Equity Fund A USD UBS Lux Equity Fund Biotech USD
1. Microsoft Corp
USA
9.79 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Nvidia Corp
USA
9.77 %
2. Moderna Inc
9.21 %
3. Apple Inc
USA
9.5 %
3. Gilead Sciences Inc
USA
4.66 %
4. Amazon.com Inc
USA
6.32 %
4. BioNTech SE
4.13 %
5. Alphabet Inc Class A
USA
4.72 %
5. Karuna Therapeutics Inc
3.75 %
6. Meta Platforms A
USA
4.69 %
-
7. Broadcom Inc
USA
3.93 %
-
8. Mastercard Inc
USA
3.54 %
-
9. Intuit Inc
3.24 %
-

The list of fund holdings was last updated on September 10, 2025.